LINDA CANTERBURY: Open Payments
NPI 1467739235 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,710 in 97 payments from 19 companies in 2025. Trend: 2023 $1,873 · 2024 $1,445 · 2025 $1,710
Food & beverage: $1,710
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $379 |
| PFIZER INC. | 21 | $297 |
| Lilly USA, LLC | 11 | $214 |
| Novo Nordisk Inc | 12 | $148 |
| Axsome Therapeutics, Inc. | 4 | $106 |
| Esperion Therapeutics, Inc. | 4 | $72 |
| Antares Pharma, Inc. | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Tandem Diabetes Care, Inc. | 2 | $49 |
Products named: NURTEC ODT, VRAYLAR, MOUNJARO, UBRELVY, Auvelity, ZEPBOUND, Wegovy, Ozempic.
Industry payments across AL — which companies pay providers there.
